Provided by Tiger Trade Technology Pte. Ltd.

Immix Biopharma, Inc.

13.66
+0.50003.80%
Post-market: 13.60-0.0600-0.44%19:30 EDT
Volume:1.51M
Turnover:20.41M
Market Cap:972.46M
PE:-15.76
High:13.76
Open:13.36
Low:13.12
Close:13.16
52wk High:13.76
52wk Low:1.94
Shares:71.19M
Float Shares:58.79M
Volume Ratio:1.00
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8667
EPS(LYR):-0.8930
ROE:-34.18%
ROA:-20.52%
PB:4.25
PE(LYR):-15.30

Loading ...

Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 27, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 12, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Major Issues Report

8-K - Current report
Dec 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2021

Correspondence

CORRESP [Cover] - Correspondence